Utilization Rates of SGLT2 Inhibitors Among Patients With Type 2 Diabetes, Heart Failure, and Atherosclerotic Cardiovascular Disease
Aliza Hussain, David J. Ramsey, Michelle Lee, Dhruv Mahtta, Muhammad Shahzeb Khan, Vijay Nambi, Christie M. Ballantyne, Laura A. Petersen, Adrienne D. Walker, Waleed Kayani, Javed Butler, Leandro Slipczuk, Joseph G. Rogers, Biykem Bozkurt, Sankar D. Navaneethan, Salim S. Virani
Topics & Concepts
MedicineHeart failureType 2 diabetesInternal medicineDiabetes mellitusAtherosclerotic cardiovascular diseaseCardiologyDiseaseEndocrinologyDiabetes Treatment and ManagementHyperglycemia and glycemic control in critically ill and hospitalized patientsHeart Failure Treatment and Management